Contents

Current Pharmaceutical Design, Volume 14 - Number 6

Editorial [ Histone Deacetylase Inhibitors Executive Editor: Dimitra Hadjipavlou-Litina ]

, 14(6): 504

Dimitra Hadjipavlou-Litina


DOI: 10.2174/138161208783885371




Chemical Origins of Isoform Selectivity in Histone Deacetylase Inhibitors

, 14(6): 505 - 528

Alan P. Kozikowski and Kyle V. Butler


DOI: 10.2174/138161208783885353




Isoform-Selective Histone Deacetylase Inhibitors

, 14(6): 529 - 544

Takayoshi Suzuki, Yukihiro Itoh and Naoki Miyata


DOI: 10.2174/138161208783885335




From Natural Products to Small Molecule Ketone Histone Deacetylase Inhibitors: Development of New Class Specific Agents

, 14(6): 545 - 561

Philip Jones and Christian Steinkuhler


DOI: 10.2174/138161208783885317




Inhibitors of NAD+ Dependent Histone Deacetylases (Sirtuins)

, 14(6): 562 - 573

Manfred Jung, Robert C. Neugebauer and Wolfgang Sippl


DOI: 10.2174/138161208783885380




Fibrate-Associated Adverse Effects Beyond Muscle and Liver Toxicity

, 14(6): 574 - 587

M. S. Elisaf, M. Florentin, E. N. Liberopoulos and D. P. Mikhailidis


DOI: 10.2174/138161208783885362




Computational Analysis of the Interaction between Ligand-Receptor Pairs

, 14(6): 588 - 592

Zhenran Jiang


DOI: 10.2174/138161208783885326




Role of Toll-Like Receptors in Immune Responses to Chlamydial Infections

, 14(6): 593 - 600

Xi Yang and A. G. Joyee


DOI: 10.2174/138161208783885344




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science